2017-11-04T12:03:10-05:00 2016-12-31 061671819 PKF O'CONNOR DAVIES LLP 500 MAMARONECK AVENUE HARRISON NY 105281633 990 2016-01-01 133299366 AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE AMER 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO PRESIDENT/CEO 2125665555 2017-11-03 1 GARRETT M HIGGINS P00543209 9143818900 2017-11-03 65.51.112.58 2017-11-03 14:30:21 ED P 8A7C0DB4DD280915B974BAAB9C167C028E1A982B FE5B3D422B6211F4B9A238507309C3023CF1D37D 2016 2018-03-14 21:41:22Z AATOD MARK W PARRINO 225 VARICK STREET 4TH FL NEW YORK NY 10014 2077630 0 X WWW.AATOD.ORG X 1984 NY TO ENHANCE THE QUALITY OF PATIENT CARE IN COMPREHENSIVE OPIOID TREATMENT PROGRAMS. 32 31 5 0 0 0 373235 478754 1515392 1598589 33 38 5479 249 1894139 2077630 0 0 0 0 428357 439783 0 0 45314 1284740 1339760 1713097 1779543 181042 298087 391935 680372 268688 259173 123247 421199 X THE AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE ("AATOD") WAS FOUNDED IN 1984 TO ENHANCE THE QUALITY OF PATIENT CARE IN TREATMENT PROGRAMS BY PROMOTING THE GROWTH AND DEVELOPMENT OF COMPREHENSIVE OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES. 0 0 804768 1031619 NATIONAL CONFERENCE- AATOD PRODUCES NATIONAL CONFERENCES ON AN EIGHTEEN MONTH CYCLE. THESE CONFERENCES PROVIDE AN OPPORTUNITY TO INTERESTED PARTIES TO LEARN ABOUT THE MOST CURRENT EVIDENCE BASED PRACTICES IN OUR FIELD. 566970 566970 RX OPIOID STUDY- TO BETTER UNDERSTAND THE IMPACT OF PRESCRIPTION OPIOID USE ON ADMISSIONS TO OPIOID TREATMENT PROGRAMS. SEVENTY FIVE TREATMENT PROGRAMS PROVIDE TREND ANALYSIS DATA. 65452 OTPS STUDY- TO INCREASE ACCESS TO THE TREATMENT OF OPIOID ADDICTION THROUGH OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES OF AMERICA. EXPENSES DIRECTLY ASSOCIATED WITH AATOD'S OPERATIONS. 1437190 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 5 1 0 0 0 0 0 0 0 0 0 0 X 32 31 0 0 0 0 1 0 0 1 1 0 0 1 1 0 0 0 0 1 0 0 NY X MARK PARRINO 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO MPA PRESIDENT/CEO 40.00 X X 169904 0 20321 JANICE F KAUFFMAN FIRST V.P. 1.00 X X 0 0 0 GEORGE E STAVROS SECOND V.P. 1.00 X X 0 0 0 MICHAEL RIZZI TREASURER 1.00 X X 0 0 0 TINA BECKLEY SECRETARY 1.00 X X 0 0 0 RICHARD BILANGI DIRECTOR 1.00 X 0 0 0 TIM BOHMAN DIRECTOR 1.00 X 0 0 0 HOLLY BROCE DIRECTOR 1.00 X 0 0 0 ROY T BROWN DIRECTOR 1.00 X 0 0 0 MOLLY CARNEY DIRECTOR 1.00 X 0 0 0 SUSAN CASE DIRECTOR 1.00 X 0 0 0 CASSITY CONDIT-ASHER DIRECTOR 1.00 X 0 0 0 BRIAN CRISSMAN DIRECTOR 1.00 X 0 0 0 EMILIA FIGUEROA GUILLEN DIRECTOR 1.00 X 0 0 0 CHERYL L GARDINE DIRECTOR 1.00 X 0 0 0 GLORIA HANANIA DIRECTOR 1.00 X 0 0 0 KEITH HOCHADEL DIRECTOR 1.00 X 0 0 0 EDWARD J HIGGINS DIRECTOR 1.00 X 0 0 0 KENNY HOUSE DIRECTOR 1.00 X 0 0 0 ANN JAMIESON DIRECTOR 1.00 X 0 0 0 JASON KLETTER DIRECTOR 1.00 X 0 0 0 BRETT LECHLEITNER DIRECTOR 1.00 X 0 0 0 SHIRLEY LINZY DIRECTOR 1.00 X 0 0 0 KATE MAHONEY DIRECTOR 1.00 X 0 0 0 CHRISTINE MARTIN DIRECTOR 1.00 X 0 0 0 BRIAN MCCARROLL DIRECTOR 1.00 X 0 0 0 PAUL MCLAUGHLIN DIRECTOR 1.00 X 0 0 0 JENNIFER MINTHORN DIRECTOR 1.00 X 0 0 0 EDWARD V OHLINGER DIRECTOR 1.00 X 0 0 0 STACEY PEARCE DIRECTOR 1.00 X 0 0 0 ALLEGRA SCHORR DIRECTOR 1.00 X 0 0 0 KENNETH STOLLER MD DIRECTOR 1.00 X 0 0 0 169904 0 20321 1 0 1 0 NATIONAL DEVELOPMENT AND RESEARCH INSTIT 71 WEST 23RD STREET 8TH FL NEW YORK NY 10010 DATA MANAGEMENT AND ANALYSIS 262707 1 137335 25000 316419 478754 NATIONAL CONFERENCE 900099 1031619 1031619 RX OPIOID STUDY 900099 566970 566970 1598589 38 38 249 249 2077630 1598589 0 287 X 190225 97183 76968 16074 180118 92199 72628 15291 8266 4154 3441 671 35345 17762 14712 2871 25829 12980 10751 2098 71469 71469 31430 17486 11044 2900 265807 265807 41957 35476 5689 792 11267 5304 5083 880 117227 38256 78971 6555 3523 2505 527 680660 668584 9976 2100 4221 2161 1702 358 1774 908 715 151 4689 2400 1891 398 PROGRAM INCENTIVES 100229 100229 MISCELLANEOUS 2475 1309 963 203 1779543 1437190 297039 45314 194122 108753 151896 165238 38049 391551 4929 13665 24971 23806 2939 1165 391935 680372 111405 109226 45555 15923 51059 50990 60669 83034 268688 259173 X 97875 404858 25372 16341 123247 421199 391935 680372 X 298087 -134 X X 0 1 X 1 0 X 326275 349921 156300 373101 478754 1684351 1271846 1277628 568124 1515392 1598589 6231579 1598121 1627549 724424 1888493 2077343 7915930 0 480550 453664 491715 535194 546194 2507317 480550 453664 491715 535194 546194 2507317 5408613 10 7 15 33 287 352 10 7 15 33 287 352 8500 12000 5141 5479 31120 1606631 1639556 729580 1894005 2077630 7947402 0.68060 0.62550 0.00000 0.00010 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2012 AMOUNT: $ 8,500. 2013 AMOUNT: $ 12,000. 2014 AMOUNT: $ 5,141. 2015 AMOUNT: $ 5,479. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 19821 19721 100 5150 4085 1065 1165 DEFERRED RENT 83034 83034 X 2077630 0 2077630 0 2077630 1779678 134 134 1779544 0 1779544 PART X, LINE 2: THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE ORGANIZATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR YEARS PRIOR TO DECEMBER 31, 2013. PART XII, LINE 2D - OTHER ADJUSTMENTS: UNCOLLECTIBLE MEMBERSHIP DUES REPORTED ON PART XI, LINE 9: 134. X X X 0 0 0 0 0 0 0 0 0 MARK W PARRINO MPA PRESIDENT/CEO 169904 0 0 0 0 0 11821 0 8500 0 190225 0 0 0 FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION OFFERS STATE MEMBERSHIP TO ORGANIZATIONS IN THE MEDICATION ASSISTED TREATMENT FIELD. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE PRESIDENT, FISCAL MANAGER, THE TREASURER, AND FINANCE COMMITTEE BEFORE FILING. THE FINAL FORM 990 IS PROVIDED TO THE FULL BOARD OF DIRECTORS BEFORE E-FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, ACTING AS THE COMPENSATION COMMITTEE, CONDUCTS ANNUAL REVIEWS OF THE PRESIDENT'S PERFORMANCE AND COMPENSATION. EVERY THIRD YEAR THE EXECUTIVE COMMITTEE REVIEWS COMPARABILITY DATA AND SETS NEW COMPENSATION LEVELS TO BE REFLECTED IN THE PRESIDENT'S THREE YEAR CONTRACT. THE CONTRACT AS PROPOSED BY THE EXECUTIVE COMMITTEE IS THEN SUBMITTED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. THIS PROCESS LAST OCCURED IN 2016. ALL DECISIONS WERE DOCUMENTED IN THE MINUTES OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 UPON REQUEST, AATOD MAKES AVAILABLE TO THE PUBLIC ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS. FORM 990, PART IX, LINE 11G PROGRAM CONSULTING: PROGRAM SERVICE EXPENSES 265,807. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 265,807. FORM 990, PART XI, LINE 9: UNCOLLECTIBLE MEMBERSHIP DUES: -134. FORM 990, PART XII, LINE 2C: AATOD HAS A FINANCE COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND SELECTION OF THE INDEPENDENT AUDITOR. THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.